The Impact of Nursing Interventions on the Treatment Outcomes of Renal Cell Carcinoma with Postoperative Interleukin-2 and Recombinant Human Interferon
Li Guo,Li-Qin Zhao,Jin-Yu Chen,Ming Li
DOI: https://doi.org/10.2147/jmdh.s447537
2024-02-17
Journal of Multidisciplinary Healthcare
Abstract:Li Guo, 1 Li-Qin Zhao, 2 Jin-Yu Chen, 2 Ming Li 2 1 Third Department of General Surgery (Breast Armor Surgery), Ezhou Central Hospital, Ezhou City, 436000, People's Republic of China; 2 Department of Oncology, Ezhou Central Hospital, Ezhou City, 436000, People's Republic of China Correspondence: Ming Li, Department of Oncology, Ezhou Central Hospital, No. 9 Wenxing Road, Echeng District, Ezhou City, Hubei Province, 436000, People's Republic of China, Tel + 86-15969693217, Email Objective: This study investigates the impact of nursing interventions on treatment outcomes and adverse reaction rates in renal cell carcinoma (RCC) patients treated postoperatively with Interleukin-2 and recombinant human Interferon. Methods: In a retrospective analysis of 90 RCC patients, 43 received standard care (control group), while 47 received additional nursing interventions (intervention group), including psychological care, vital signs monitoring, dietary care, adverse reaction management, and post-discharge care. Patients with concurrent major diseases or other malignancies were excluded. Key assessments included clinical symptom improvement, treatment efficacy, and postoperative adverse reactions. Results: Among the 90 participants, no significant demographic differences were found between the two groups. The intervention group showed significant improvements in fever resolution, leukocyte normalization, and shorter hospital stays. The overall treatment effectiveness was similar in both groups (90.7% in the intervention group vs 91.5% in the control group). However, the intervention group experienced significantly fewer postoperative adverse reactions, including fever, gastrointestinal symptoms, bone marrow suppression, and neurological abnormalities (6.3% vs 23.2%). Conclusion: The study suggests that nursing interventions can improve treatment outcomes by reducing postoperative adverse reactions in RCC patients receiving postoperative Interleukin-2 and recombinant human Interferon. The overall effectiveness of treatment and care was comparable between the groups. Further extensive studies are needed to confirm these findings and fully understand the impact of nursing interventions on RCC patient outcomes. Keywords: renal cell carcinoma, interleukin-2, recombinant human interferon, nursing interventions, treatment outcomes, adverse reactions Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, accounting for approximately 90% of all renal neoplasms. 1 Over the past few decades, advancements in surgical techniques and adjuvant therapies have substantially improved the prognosis of RCC patients. Among these, postoperative treatment with Interleukin-2 (IL-2) and recombinant human Interferon has emerged as a potentially effective therapeutic approach. 2,3 Adverse events documented with the use of high-dose IL-2 include hypotension, pre-renal azotemia, oliguria, and pulmonary edema. Pulmonary edema has been postulated to be caused by IL-2 activated NK cells and direct effect on vascular endothelium leading to capillary leak syndrome. Neurologic changes are one of the most common toxicities associated with high-dose IL-2 therapy. Hypotension, as a result of capillary leak syndrome, was one of the most commonly reported side effects from IL-2 treatment among the studies. Lower doses, prolonged infusions, and subcutaneous administration have been evaluated as strategies for improving IL-2 tolerability, but these regimens have produced response rates lower than those produced with high-dose regimens. 4–7 Nursing interventions have been widely recognized as a critical component of comprehensive cancer care. 8 By encompassing psychological care, vital sign monitoring, dietary guidance, adverse reaction management, and post-discharge care, nursing interventions can potentially enhance treatment adherence, improve symptom management, and alleviate adverse reactions. 9,10 These holistic interventions can play a significant role in improving patients' quality of life and overall treatment outcomes. 11 However, existing literature lacks specific investigations into the impact of nursing interventions on the outcomes of RCC patients undergoing postoperative IL-2 and recombinant human Interferon therapy. Given this gap in the literature, the present study aims to assess the effectiveness of nursing interventions on treatment outcomes and adverse reaction rates in this particular patient population. A retrospective cohort study design was implemented, with data being sourced from medical records of RCC patients who underwent postoperative treatment with Interleukin-2 (IL-2) and recombinant human Interferon at -Abstract Truncated-
health care sciences & services